Publications &
Presentations

November 2024
Collaborating for Novel Solutions (CNS) Summit 2024

Profiling of drug response mechanisms and patient sub-populations through readouts from a biobank of patient-derived neurons
Collaboration with NeuroKaire: Daphna Laifenfeld PhD, Tal Birnberg PhD, David Pattison, Claudia Albeldas, Elena Kagan

Learn More
CLE
100
September 2024
7th Neuropsychiatric Drug Development Summit

Introducing CLE-905, a Potent Dual M1/M4 Receptor Agonist in Development for Treatment of Schizophrenia and Additional Psychiatric Disorders
Hadile Ounallah-Saad, PhD

Learn More
CLE
905
May 2023
American Society of Clinical Psychopharmacology (ASCP) 2023

A Phase 2 Randomized Controlled Adjunctive Treatment Trial with CLE-100 Esketamine Tablet for Patients with Major Depressive Disorder and Inadequate Response to Antidepressants, During the COVID-19 Pandemic
Maurizio Fava, Oren Berkowitz, Sanjay J. Mathew, Michael E. Thase, Andrew A. Nierenberg, Dan V. Iosifescu, L. Alison McInnes, Cristina Cusin, Robert Berman, Eli Eyal, Ari Gershon, Esther Lukasiewicz-Hagai

Learn More
CLE
100
Skip to content